Cambrian Bio Investor

Clinical-stage drug development companyВідповідно до джерел: 4Cambrian Bio is a clinical-stage drug development company building the medicines that will redefine healthcare in the 21st century – therapeutics to treat, and ultimately prevent, some of today’s most debilitating chronic Bio | Catalyzing Bio is a clinical-stage drug development company building the medicines that will modernize healthcare in the 21st century. Our focus lies in creating innovative therapeutics designed to prevent diseases and lengthen healthspan—the period of life Bio - Bio is a clinical-stage drug development company building the medicines that will modernize healthcare in the 21st century. Our focus lies in creating innovative therapeutics designed to prevent diseases and lengthen healthspan—the period of life Bio - Bio is a clinical-stage drug development company building the medicines that will modernize healthcare in the 21st century. Our focus lies in creating innovative therapeutics designed to prevent diseases and lengthen healthspan—the period of life Bio -

Technology: Biotechnology
Headquarters: Brooklyn, New York, Cambrian BioPharma, United States
Founded Date: 2019.0
Industry: Biotechnology
Employee Number: 17
Estimated Revenue: $164.75M